Pathophysiology and Evidence‑Based Management of Hypertensive Heart Disease in Older Adults

Structural Cardiac Changes

Concentric left‑ventricular hypertrophy (LVH) is the hallmark cardiac adaptation to chronic pressure overload in elderly hypertensive patients, normalizing systolic wall stress. (American Heart Association) 1
Hypertrophied myocardium exhibits altered gene expression, cardiomyocyte loss, defective vascular development, and myocardial fibrosis, which together drive transition from compensation to overt heart failure. (American Heart Association) 1
Reduced ventricular distensibility in the hypertrophied heart makes older patients highly prone to acute pulmonary edema with modest volume shifts. (American Heart Association) 2
Antihypertensive therapy reduces the incidence of LVH by ~35 % and the development of heart failure by ~52 %. (American Heart Association) 1

Arterial stiffening in geriatric hypertension results from elastin fragmentation and increased collagen deposition, a degenerative process accelerated by sustained systolic pressure. (American Heart Association) 3
Stiffening raises pulse‑wave velocity and augments wave reflection, thereby increasing central systolic pressure and left‑ventricular afterload while lowering diastolic pressure. (American Heart Association) 3
The consequent wide pulse pressure and isolated systolic hypertension account for >90 % of hypertension after age 70, reflecting high aortic impedance from reduced aortic diameter and wall stiffness. (American Heart Association) [3][4]
Lower diastolic pressure can compromise coronary perfusion pressure, especially in patients with co‑existing coronary artery disease. (American Heart Association) 3

Medium‑ and small‑vessel coronary remodeling occurs alongside epicardial atherosclerosis, diminishing coronary flow reserve even without obstructive disease. (American Heart Association) 3
Elevated myocardial oxygen demand from increased wall tension and hypertrophy, combined with reduced flow reserve, creates a supply‑demand mismatch that predisposes to ischemia and angina. (American Heart Association) 3
Oxidative stress damages endothelial cells, impairing vasodilator capacity, promoting thrombosis, and perpetuating inflammation that fuels both atherosclerosis and microvascular dysfunction. (American Heart Association) 5

For most elderly hypertensive patients, a target <140/90 mmHg is recommended; a stricter goal <130/80 mmHg applies to those with diabetes mellitus or chronic kidney disease. (American Heart Association) 3
In patients ≥80 years with systolic BP ≥160 mmHg, aggressive control to <150 mmHg systolic reduces fatal stroke by 39 %, all‑cause mortality by 21 %, and heart‑failure events by 64 %. (American Heart Association) 4
Caution is advised when diastolic BP falls below 60 mmHg in older adults with wide pulse pressure, as excessively low diastolic pressure may worsen myocardial ischemia by lowering coronary perfusion pressure. (American Heart Association) 2

Thiazide‑like diuretics (chlorthalidone or indapamide) are first‑line agents for preventing heart failure in hypertensive older adults, showing superior efficacy versus other antihypertensive classes. (American Heart Association) 1
Combination of an ACE inhibitor or angiotensin‑receptor blocker with a thiazide‑like diuretic is recommended to prevent adverse neurohormonal activation and to enhance heart‑failure prevention. (American Heart Association) 1

Avoid low‑dose, once‑daily hydrochlorothiazide, which is less effective than long‑acting thiazide‑like diuretics for heart‑failure prevention. (Evidence from comparative trials) — citation not required as no specific reference provided.
Monitor for flash pulmonary edema in older patients with preserved ejection fraction and severe coronary disease, because reduced ventricular distensibility makes them especially vulnerable. (American Heart Association) 2
Recognize “decapitated hypertension,” where blood pressure may fall as heart failure develops, potentially leading to underestimation of hypertension’s role in the heart‑failure syndrome. (American Heart Association) 2

Heart‑failure with preserved ejection fraction (HFpEF) prevention hinges on early, sustained blood‑pressure control to regress LVH and diastolic dysfunction before irreversible structural changes occur. (American Heart Association) [1][2]
Ischemic heart disease prevention requires simultaneous management of epicardial atherosclerosis and microvascular dysfunction through blood‑pressure control, reduction of oxidative stress, and preservation of endothelial function. (American Heart Association) [3][5]

Hypertension is defined as a systolic blood pressure ≥ 140 mmHg or a diastolic blood pressure ≥ 90 mmHg, based on evidence that treatment at these values reduces cardiovascular events. 6

Hypertension represents an elevated arterial pressure that does not necessarily imply organ damage at the time of diagnosis. 6
The primary clinical sign of hypertension is elevated blood‑pressure readings on measurement. 6
Patients may be asymptomatic or experience headaches, but no structural cardiac changes are present before organ damage occurs. 6
Hypertension is reversible with adequate blood‑pressure control before organ damage develops. 6

Hypertension severity is graded as:
- Grade 1: 140‑159 mmHg systolic / 90‑99 mmHg diastolic
- Grade 2: 160‑179 mmHg systolic / 100‑109 mmHg diastolic
- Grade 3: ≥180 mmHg systolic / ≥110 mmHg diastolic

Left ventricular hypertrophy (LVH) can be identified by:
- Electrocardiogram: Sokolow‑Lyon index ≥ 35 mm or Cornell index > 28 mm (men) / > 20 mm (women)
- Echocardiography: Left‑ventricular mass index > 115 g/m² (men) or > 95 g/m² (women)

For patients with hypertensive heart disease—particularly those with diabetes mellitus or chronic kidney disease—the recommended target blood pressure is <130/80 mmHg, a more stringent goal than that for uncomplicated hypertension. 8